← Back
$RPRX All transactions

Royalty Pharma plc

A

$ Value

$0

Shares

19,970

Price

$0

Filed

Feb 13

Insider

Name

Urist Marshall

Title

EVP, Research & Investments

CIK

0001838139

Roles

Officer

Transaction Details

Transaction Date

2026-02-11

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

27,368

Footnotes

Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.

Filing Info

Accession No.

0001838139-26-000012

Form Type

4

Issuer CIK

0001802768

Urist Marshall's History

Date Ticker Type Value
2026-02-11 RPRX A $0
2026-01-30 RPRX $822K
2026-01-23 RPRX $805K
2026-01-16 RPRX $790K
2026-01-09 RPRX $816K
2026-01-02 RPRX $770K
2025-12-26 RPRX $786K
2025-12-19 RPRX $768K
2025-12-16 RPRX $766K
2025-12-05 RPRX $914K

Other Insiders at RPRX (90d)

Insider Bought Sold Last
Legorreta Pablo G.
CEO, Chairman of the Board
2026-02-11
Bassler Bonnie L 2026-03-31
Hite Christopher
EVP & Vice Chairman
2026-02-11
Coyne Terrance P.
EVP & CFO
$16.8M 2026-04-01
Urist Marshall
EVP, Research & Investments
$822K 2026-01-30